Israel - engelska - Ministry of Health

a.m.i. medical technologies limited, israel - adapalene; benzoyl peroxide - gel - benzoyl peroxide 25 mg/g; adapalene 1 mg/g - benzoyl peroxide - cutaneous treatment of acne vulgaris when comedones, papules and pustules are present.

USA - engelska - NLM (National Library of Medicine)

cintex services, llc - benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm) - benzoyl peroxide 100 mg in 1 g - for the treatment of acne - have very sensitive skin - are sensitive to benzoyl peroxide stop use and ask a doctor if   irritation becomes severe.

Australien - engelska - APVMA (Australian Pesticides and Veterinary Medicines Authority)

trical australia pty ltd - ethylene oxide - pressurised gas - ethylene oxide gas active 90.0 g/kg - sanitiser - bristles | ceramic product | clock | clothes - refer to label | cosmetics - where eto cannot access | electrical components | fo - bacteria | insect | insect eggs | mould | virus

USA - engelska - NLM (National Library of Medicine)

axia medical solutions, llc - benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm) - benzoyl peroxide 50 mg in 1000 mg - acne treatment for the treatment of acne. • have sensitive skin. • are sensitive to benzoyl peroxide. irritation become severe.

USA - engelska - NLM (National Library of Medicine)

axia medical solutions, llc - benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm) - benzoyl peroxide 100 mg in 1 g - acne treatment for the treatment of acne. • have sensitive skin. • are sensitive to benzoyl peroxide. irritation become severe.

USA - engelska - NLM (National Library of Medicine)

antares pharma, inc. - hyaluronidase (human recombinant) (unii: 743quy4vd8) (hyaluronidase (human recombinant) - unii:743quy4vd8) - hyaluronidase (human recombinant) 150 [usp'u] in 1 ml - hylenex recombinant is indicated as an adjuvant in subcutaneous fluid administration for achieving hydration. hylenex recombinant is indicated as an adjuvant to increase the dispersion and absorption of other injected drugs. hylenex recombinant is indicated as an adjunct in subcutaneous urography for improving resorption of radiopaque agents. hylenex recombinant is contraindicated in patients with known hypersensitivity to hyaluronidase or any of the excipients in hylenex recombinant. discontinue hylenex recombinant if sensitization occurs. risk summary there are no adequate and well-controlled studies of hylenex recombinant administration in pregnant women to inform a drug-associated risk. subcutaneous administration of hylenex recombinant to pregnant mice throughout organogenesis did not produce teratogenic effects at clinically relevant doses. administration of hylenex recombinant to mice in a pre-/postnatal study did not produce adverse effects on offspring at clinically relevant doses. human data limited available data with hylenex recombinant in pregnant women have not identified any potential risks. animal data in an embryofetal development study, subcutaneous administration of hyaluronidase to pregnant mice throughout organogenesis produced reduced fetal weight and increased numbers of fetal resorptions at daily doses greater or equal to 3 mg/kg (approximately 360,000 usp units/kg). no malformations were produced at any dose up to approximately 18 mg/kg (approximately 2,200,000 usp units/kg). these doses are several orders of magnitude greater than the maximum recommended human dose (5 usp units/kg). in a pre- and postnatal development study, mice were dosed daily by subcutaneous injection with hyaluronidase at dose levels up to 9 mg/kg (approximately 1,100,000 usp units/kg). the study found no adverse effects on sexual maturation, learning and memory of offspring, or their ability to produce another generation of offspring. risk summary there is no information regarding the presence of hylenex recombinant in human milk, the effects on the breastfed infants, or the effects on milk production to inform risk of hylenex recombinant to an infant during lactation. the developmental and health benefits of breastfeeding should be considered along with the mother's clinical need for hylenex recombinant. clinical hydration requirements for children can be achieved through administration of subcutaneous fluids facilitated with hylenex recombinant. the dosage of subcutaneous fluids administered is dependent upon the age, weight, and clinical condition of the patient as well as laboratory determinations. the potential for chemical or physical incompatibilities should be kept in mind [see drug interactions (7)]. the rate and volume of subcutaneous fluid administration should not exceed those employed for intravenous infusion. for premature infants or during the neonatal period, the daily dosage should not exceed 25 ml/kg of body weight, and the rate of administration should not be greater than 2 ml per minute. during subcutaneous fluid administration, special care must be taken in pediatric patients to avoid over hydration by controlling the rate and total volume of the infusion [see dosage and administration (2.1)]. no overall differences in safety or effectiveness have been observed between elderly and younger adult patients.

Australien - engelska - APVMA (Australian Pesticides and Veterinary Medicines Authority)

trical australia pty ltd - ethylene oxide - pressurised gas - ethylene oxide gas active 1000.0 g/kg - mixed function pesticide - bristles | ceramic product | clock | clothes - refer to label | cosmetics - where eto cannot access | electrical components | fo - bacteria | insect | insect eggs | mould | virus

Australien - engelska - APVMA (Australian Pesticides and Veterinary Medicines Authority)

buckman laboratories pty ltd - methylene bis(thiocyanate) - unknown - methylene bis(thiocyanate) cyanide active 0.0 - active constituent

Kanada - engelska - Health Canada

laboratoire atlas inc - methylene blue - liquid - 1% - methylene blue 1% - miscellaneous therapeutic agents

Kanada - engelska - Health Canada

laboratoire atlas inc - methylene blue - liquid - 2% - methylene blue 2% - antidotes